These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30515631)

  • 1. Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS).
    Johnen A; Bürkner PC; Landmeyer NC; Ambrosius B; Calabrese P; Motte J; Hessler N; Antony G; König IR; Klotz L; Hoshi MM; Aly L; Groppa S; Luessi F; Paul F; Tackenberg B; Bergh FT; Kümpfel T; Tumani H; Stangel M; Weber F; Bayas A; Wildemann B; Heesen C; Zettl UK; Zipp F; Hemmer B; Meuth SG; Gold R; Wiendl H; Salmen A;
    J Neurol; 2019 Feb; 266(2):386-397. PubMed ID: 30515631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis.
    Carotenuto A; Moccia M; Costabile T; Signoriello E; Paolicelli D; Simone M; Lus G; Brescia Morra V; Lanzillo R;
    Sci Rep; 2019 Dec; 9(1):18074. PubMed ID: 31792347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early effective treatment may protect from cognitive decline in paediatric multiple sclerosis.
    Johnen A; Elpers C; Riepl E; Landmeyer NC; Krämer J; Polzer P; Lohmann H; Omran H; Wiendl H; Göbel K; Meuth SG
    Eur J Paediatr Neurol; 2019 Nov; 23(6):783-791. PubMed ID: 31540711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective effects of high-education levels on cognition in different stages of multiple sclerosis.
    Rimkus CM; Avolio IMB; Miotto EC; Pereira SA; Mendes MF; Callegaro D; Leite CDC
    Mult Scler Relat Disord; 2018 May; 22():41-48. PubMed ID: 29554549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does vitamin D deficiency predict early conversion of clinically isolated syndrome? A preliminary Egyptian study.
    Shaheen HA; Sayed SS; Daker LI; AbdelAziz HE; Taha MA
    Int J Neurosci; 2018 Oct; 128(10):946-951. PubMed ID: 29493311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a brief electronic screening test for cognitive impairment in multiple sclerosis (SCI-MS Test).
    Meca-Lallana JE; Prieto-González JM; Jimenez-Veiga J; Carreón-Guarnizo E; Jiménez-Martín I; Hernández-Clares R; Sistiaga-Berrondo A; Carles-Dies R; García-Molina E; Cerdán-Sánchez M; Costa-Arpín E; Croitoru I; Castillo-Triviño T; Iniesta-Martinez F; García-Pérez E; Olascoaga-Urtaza J
    Mult Scler Relat Disord; 2019 Feb; 28():50-56. PubMed ID: 30553169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive deficits including executive functioning in relation to clinical parameters in paediatric MS patients.
    Wuerfel E; Weddige A; Hagmayer Y; Jacob R; Wedekind L; Stark W; Gärtner J
    PLoS One; 2018; 13(3):e0194873. PubMed ID: 29566099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline.
    Wallach AI; Waltz M; Casper TC; Aaen G; Belman A; Benson L; Chitnis T; Gorman M; Graves J; Harris Y; Lotze TE; Mar S; Moodley M; Ness JM; Rensel M; Rodriguez M; Rose JW; Schreiner T; Tillema JM; Waubant E; Weinstock-Guttman B; Charvet LE; Krupp LB
    Mult Scler; 2020 Dec; 26(14):1938-1947. PubMed ID: 31775571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage.
    Ziccardi S; Tamanti A; Ruggieri C; Guandalini M; Marastoni D; Camera V; Montibeller L; Mazziotti V; Rossi S; Calderone M; Pizzini FB; Montemezzi S; Magliozzi R; Calabrese M
    Neurol Neuroimmunol Neuroinflamm; 2024 Nov; 11(6):e200301. PubMed ID: 39178066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis.
    Reuter F; Zaaraoui W; Crespy L; Faivre A; Rico A; Malikova I; Soulier E; Viout P; Ranjeva JP; Pelletier J; Audoin B
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1157-9. PubMed ID: 20971755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of cognitive function in multiple sclerosis: is decline inevitable?
    Katsari M; Kasselimis DS; Giogkaraki E; Breza M; Evangelopoulos ME; Anagnostouli M; Andreadou E; Kilidireas C; Hotary A; Zalonis I; Koutsis G; Potagas C
    J Neurol; 2020 May; 267(5):1464-1475. PubMed ID: 32008073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis.
    Hynčicová E; Vyhnálek M; Kalina A; Martinkovič L; Nikolai T; Lisý J; Hort J; Meluzínová E; Laczó J
    J Neurol; 2017 Mar; 264(3):482-493. PubMed ID: 28028623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing Detection and Prediction of Cognitive Function in Multiple Sclerosis With Ambulatory Cognitive Tests: Protocol for the Longitudinal Observational CogDetect-MS Study.
    Kratz AL; Ehde DM; Alschuler KN; Pickup K; Ginell K; Fritz NE
    JMIR Res Protoc; 2024 Sep; 13():e59876. PubMed ID: 39325510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T
    Louapre C; Govindarajan ST; Giannì C; Madigan N; Nielsen AS; Sloane JA; Kinkel RP; Mainero C
    Neuroimage Clin; 2016; 12():879-886. PubMed ID: 27872810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-year longitudinal follow-up of cognitive performance assessed by BICAMS in newly diagnosed patients with MS.
    Skorve E; Lundervold AJ; Torkildsen Ø; Myhr KM
    Mult Scler Relat Disord; 2020 Nov; 46():102577. PubMed ID: 33296975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study.
    Pitteri M; Romualdi C; Magliozzi R; Monaco S; Calabrese M
    Mult Scler; 2017 May; 23(6):848-854. PubMed ID: 27527906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-modal neuroimaging signatures predict cognitive decline in multiple sclerosis: A 5-year longitudinal study.
    Al-Iedani O; Lea S; Alshehri A; Maltby VE; Saugbjerg B; Ramadan S; Lea R; Lechner-Scott J
    Mult Scler Relat Disord; 2024 Jan; 81():105379. PubMed ID: 38103511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and Behavioral Functioning in Childhood Acquired Demyelinating Syndromes.
    Till C; Noguera A; Verhey LH; O'Mahony J; Yeh EA; Mah JK; Sinopoli KJ; Brooks BL; Aubert-Broche B; Collins DL; Narayanan S; Arnold DL; Banwell BL
    J Int Neuropsychol Soc; 2016 Nov; 22(10):1050-1060. PubMed ID: 27903328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cognitive reserve in multiple sclerosis: A cross-sectional study in 526 patients.
    Artemiadis A; Bakirtzis C; Ifantopoulou P; Zis P; Bargiotas P; Grigoriadis N; Hadjigeorgiou G
    Mult Scler Relat Disord; 2020 Jun; 41():102047. PubMed ID: 32182469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.